Advertisement

Topics

Latest "Sciences Corporation" News Stories

18:18 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Sciences Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Sciences Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sciences Corporation for you to read. Along with our medical data and news we also list Sciences Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sciences Corporation Companies for you to search.

Showing "Sciences Corporation" News Articles 1–25 of 4,600+

Relevant

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated person...


Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and t...


Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated pe...

Orion Corporation: Managers' transactions - Heikki Westerlund

ORION CORPORATION      MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Heikki Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their...

Orion Corporation: Managers' transactions - Agendum Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 30 APRIL 2018 at 17.15 EEST Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they discuss: • Almac Sciences' functions and its clients • The Almac Sciences business model • Almac Sciences' functions and its clients • Sharing risks and collaborations • The future for Alma...

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their c...

Urovant Sciences nets $130.2mm in Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. netted $130.2mm in an initial public offering of 10m...

#Cannabisstocks: ( $CVSI) CV Sciences, Inc.'s PlusCBD Oil featured on Oct. 3rd Episode of ‘The Dr. Oz Show'

October 9, 2018 (Investorideas.com Newswire) CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated...

CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable (“Promissory Note”) to Wiltshire, LLC in cash, thus avoiding … Continue reading → Cet article CV Sciences, Inc. Repays Remaining Debt est apparu en premier sur Bi...

Urovant Sciences files for Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.

Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä

ORION CORPORATION         MANAGERS' TRANSACTIONS 8 MAY 2018 at 16.30 EETS Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associ...

wikifolio whispers p.m. zu Gilead Sciences, Nemetschek, E.ON ...

Gilead Sciences 0.49% DerProfessor (POWREV01): Biotech schwächelt. In diesem Umfeld wird auch GILEAD auf längere Sicht nicht performen. (14.05. 12:11) >> mehr comments zu Gilead Sciences: www.boers...

German Academies of Sciences offer recommendations for the reform of doctoral practices

(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in English, by the German National Academy of Sciences Leopoldina, acatech - National Academy of Sciences and Engineering, and the Union of the German Academies of Sciences and Humanities.

Roivant Launches New China-Based Startup Sinovant Sciences

Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.

Roivant launches new startup Sinovant Sciences in China

Global healthcare company Roivant Sciences has launched a spin-off called Sinovant Sciences in Shanghai, China to primarily develop innovative therapeutics...Read More... The post Roivant launches new startup Sinovant Sciences in China appeared first on Pharmaceutical Technology.

A bigger, better Office for Life Sciences

The Department for Business, Innovation and Skills (BIS) and the Department of Health (DH) are joining their life sciences functions to create a new, expanded Office for Life Sciences.BIS and DH have appointed Nicole Mather as the Director for the new Office for Life Sciences. Nicole has a DPhil in Neuroscience and is a Director in Deloitte’s Healthcare and Life Sciences practice. She will t...

International Stem Cell Corporation Granted Key Patent in US

CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a key patent (US9926529B2) on ...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab (“OGGL”). Mr. Vinson has over 35-years experience in managing the marketing efforts for innovative technology in emerging markets. He began sales efforts in the technology s...

Catalent to Provide Manufacturing for GB Sciences’ Proprietary Parkinson’s Disease Therapies

NewsGB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease.

Lauren Sciences LLC awarded third grant for LAUR-301 from The ALS Association

(Lauren Sciences LLC) Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced the award of its third grant from The ALS Association. The ALS Association grant will support Lauren Sciences continued development of LAUR-301, its novel V-Smart® Nanomedicine for ALS (amyotrophic lateral sclerosis), also know...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks